Bausch Health Companies Inc. BHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.98% | 10.36% | 8.45% | 6.70% | 5.80% |
| Total Other Revenue | -4.42% | -11.97% | -11.30% | 2.80% | 10.78% |
| Total Revenue | 10.81% | 10.09% | 8.22% | 6.66% | 5.86% |
| Cost of Revenue | 3.43% | 5.89% | 7.28% | 8.30% | 6.59% |
| Gross Profit | 13.87% | 11.84% | 8.61% | 5.99% | 5.56% |
| SG&A Expenses | 3.48% | 0.67% | 2.14% | 4.48% | 4.05% |
| Depreciation & Amortization | -9.28% | -8.61% | -6.89% | -7.06% | -6.91% |
| Other Operating Expenses | 83.33% | -- | -- | -- | -- |
| Total Operating Expenses | 1.70% | 1.88% | 3.08% | 3.98% | 3.34% |
| Operating Income | 45.76% | 44.59% | 29.94% | 17.79% | 16.78% |
| Income Before Tax | -167.88% | -360.50% | -597.35% | 119.76% | 1,161.22% |
| Income Tax Expenses | 138.69% | 54.94% | 5.56% | 3.35% | 18.45% |
| Earnings from Continuing Operations | -357.94% | -2,377.08% | -1,412.35% | 266.67% | 247.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -131.71% | -110.00% | -58.54% | 42.31% | 5.13% |
| Net Income | -332.32% | -1,220.41% | -2,920.00% | 441.30% | 303.37% |
| EBIT | 45.76% | 44.59% | 29.94% | 17.79% | 16.78% |
| EBITDA | 26.49% | 24.74% | 16.17% | 8.71% | 7.63% |
| EPS Basic | -332.81% | -1,227.39% | -2,831.16% | 431.41% | 299.63% |
| Normalized Basic EPS | 142.50% | 133.39% | 33.69% | 27.70% | 36.92% |
| EPS Diluted | -336.00% | -1,244.39% | -2,755.47% | 422.21% | 298.59% |
| Normalized Diluted EPS | 142.08% | 132.05% | 33.18% | 27.12% | 36.23% |
| Average Basic Shares Outstanding | 0.86% | 0.78% | 0.71% | 0.68% | 1.79% |
| Average Diluted Shares Outstanding | 0.99% | 1.12% | 0.98% | 0.96% | 2.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |